First-Line Treatment for Essential Tremor
Propranolol is the most established and recommended first-line medication for essential tremor, with demonstrated efficacy for over 40 years and should be initiated when tremor symptoms interfere with function or quality of life. 1
First-Line Treatment Options
- Propranolol (a beta-blocker) is recommended as first-line therapy by the American Academy of Neurology and can improve tremor in approximately 50% of patients 1, 2
- Primidone is an equally effective first-line alternative that can be used if propranolol is contraindicated or not tolerated 1, 3
- Treatment should only be initiated when tremor causes functional disability that impacts quality of life 1, 2
Propranolol Considerations
- Propranolol has shown improvement in tremor in clinical trials, particularly for upper extremity tremor 4
- Typical dosing starts at 40mg twice daily and can be titrated up to 120mg daily based on response 4
- Contraindications include chronic obstructive pulmonary disease, bradycardia, and congestive heart failure 1
- Common side effects include lethargy, depression, dizziness, hypotension, and sleep disturbances 1
- For patients with both essential tremor and hypertension, propranolol provides dual benefits 1
Primidone Considerations
- Primidone is equally effective as propranolol for essential tremor control 1, 3
- Primidone works by blocking voltage-gated sodium channels and modulating GABA-A and GABA-B intracortical circuits 5
- Side effects may include sedation, dizziness, and nausea, particularly during initiation 2
Treatment Algorithm
Initial Assessment:
First-Line Treatment:
Inadequate Response:
Second-Line Options:
Refractory Cases:
Common Pitfalls and Caveats
- Beta-blockers should be avoided in patients with asthma, COPD, heart block, or heart failure 1
- In elderly patients, excessive heart rate reduction with beta-blockers may lead to serious adverse events 1
- No medication can cure essential tremor or slow its progression; treatment is purely symptomatic 2
- Medication efficacy is limited, with approximately 50% of patients experiencing improvement 2
- Patients should be monitored for side effects and efficacy, with dose adjustments as needed 1